Newsroom
Editorial: Can Gene Signatures Tell Us All?
The writer asks: is more information better, even if we don't understand what it means?
BRCA2 Mutation: Poor Prognosis in Prostate Cancer
The study, published in the British Journal of Cancer, observed poor survival at the end of the follow-up period in men carrying the mutation, compared to non-carriers.
Model Evaluates Efficient Use of the PSA Test
The analysis recommends conducting the PSA test in those less than 70 years of age, to avoid overdiagnosis while reducing death by at least 50%.
Report Provides Retrospective Analysis of Medicare Part D and Provisions under ACA
A new Kaiser Family Foundation report analyzes key trends that have shaped the Medicare Part D marketplace since the program launched nine years ago, providing a detailed assessment of changes in plan availability, enrollment, premiums and cost sharing in both private stand-alone drug plans, and Medicare Advantage drug plans.
Study Identifies Need for Standardizing Blood Test Charges
The study identified that there are no set methods to determine cost for a particular test.
In Massachusetts, Nearly 400,000 Will Seek Reinsurance
People who bought state plans instead of seeking insurance through their employer, have to go through the process again due to a temporary fix that was afforded.
Two Leading Cancer Organizations, ASCO and AACR, Take a Stand on E-Cigarettes
ASCO and AACR want to see stricter regulation of the products, touching various aspects such as flavors, child-proofing, refills etc.
Medicare Proposes Covering Newly Approved Cologuard Test for CRC Detection
The final decision on the proposal will be made only after a 30-day comment period.
"Value" Decision by NICE Met With Disapproval
Both, the scientific community and a charitable organization, Prostate Cancer UK, have criticized the drug approval body for not offering abiraterone to sufferers until after chemotherapy.
First-Ever Surgery To Replace a Failing Tricuspid Heart Valve
For the first time in the United States, doctors used a minimally invasive procedure to replace a failing, hard-to-reach heart valve with a new one – and placed it just outside the heart.
Bevacizumab Receives FDA Approval for Late-Stage Cervical Cancer
Marketed by Genentech, Avastin received priority review following encouraging safety and efficacy results.
FDA Issues Warning on Fraudulent Ebola Prevention And Treatment Products
The FDA, in a press release, has warned consumers to be aware of such products being sold online.
Employers Offer High-Deductible Plans To Save Costs
To keep their healthcare costs in check, employers are shifting the cost equation by increasing employee premiums.
Fifteen-Year Study Identifies BMI as a Risk Factor for Ten Cancers
The study, published in Lancet, reaffirms that being obese and overweight can be a major health burden and can lead to various other diseases.
Hospitals Helping Out With Premiums on Policies Bought Through Exchanges
However, insurers want the government to intervene and restrict the practice.
Ethics and Social Media—Where Do We Draw the Line?
A recent Facebook study has initiated a debate on privacy and ethicis concerns, with the Federal Trade Commission saying they'll soon be involved as well.
Amgen's Kyprolis Fails in Phase 3 MM Trial
Kyprolis failed to improve survival in the phase 3 FOCUS trial in patients who had relapse following at least 3 prior regimens.